share_log

藥明生物：翌日披露報表

WUXI BIO: Next Day Disclosure Return

香港交易所 ·  Apr 11 22:06
Summary by Futu AI
药明生物技术有限公司於2024年4月11日提交了翌日披露報表，披露了自2023年12月7日至2024年4月10日期間的股份購回活動。該公司在此期間進行了多次股份購回，但並未註銷這些股份。此外，公司亦根據股份期權計劃於2024年4月8日至10日行使期權，發行了共計165,000股新股，發行價格遠低於市價。根據報表，药明生物確認已遵守所有相關的法律規定及上市規則，並已收取全部款項。截至2024年4月11日，公司的結存已發行股份為4,259,135,569股。
药明生物技术有限公司於2024年4月11日提交了翌日披露報表，披露了自2023年12月7日至2024年4月10日期間的股份購回活動。該公司在此期間進行了多次股份購回，但並未註銷這些股份。此外，公司亦根據股份期權計劃於2024年4月8日至10日行使期權，發行了共計165,000股新股，發行價格遠低於市價。根據報表，药明生物確認已遵守所有相關的法律規定及上市規則，並已收取全部款項。截至2024年4月11日，公司的結存已發行股份為4,259,135,569股。
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 11, 2024 DISCLOSING SHARE REPURCHASE ACTIVITIES FOR THE PERIOD FROM DECEMBER 7, 2023 TO APRIL 10, 2024. The company has made several share repurchases during this period, but has not written them off. In addition, the Company issued a total of 165,000 new shares under the share option plan to exercise options from 8 to 10 April 2024 at a price well below the market price. According to the report, Pharma Biologics confirmed that it has complied with all relevant legal requirements and listing rules and has been paid in full. As of April 11, 2024, the Company's outstanding shares were 4,259,135,569 shares.
PHARMA MING BIOTECHNOLOGY CO., LTD. FILED A NEXT DAY DISCLOSURE REPORT ON APRIL 11, 2024 DISCLOSING SHARE REPURCHASE ACTIVITIES FOR THE PERIOD FROM DECEMBER 7, 2023 TO APRIL 10, 2024. The company has made several share repurchases during this period, but has not written them off. In addition, the Company issued a total of 165,000 new shares under the share option plan to exercise options from 8 to 10 April 2024 at a price well below the market price. According to the report, Pharma Biologics confirmed that it has complied with all relevant legal requirements and listing rules and has been paid in full. As of April 11, 2024, the Company's outstanding shares were 4,259,135,569 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.